Hiroshi Uchino

6.5k total citations · 3 hit papers
115 papers, 5.2k citations indexed

About

Hiroshi Uchino is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Plant Science. According to data from OpenAlex, Hiroshi Uchino has authored 115 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Molecular Biology and 18 papers in Plant Science. Recurrent topics in Hiroshi Uchino's work include Diabetes Treatment and Management (14 papers), Diabetes Management and Research (12 papers) and Metabolism, Diabetes, and Cancer (12 papers). Hiroshi Uchino is often cited by papers focused on Diabetes Treatment and Management (14 papers), Diabetes Management and Research (12 papers) and Metabolism, Diabetes, and Cancer (12 papers). Hiroshi Uchino collaborates with scholars based in Japan, India and Canada. Hiroshi Uchino's co-authors include Hitoshi Endou, Eiji Takeda, Yoshikatsu Kanai, Ken‐ichi Miyamoto, Hiroko Segawa, Ryuzo Kawamori, Ikumi Tamai, Yoshimichi Sai, Takahisa Hirose and Hirotaka Watada and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Science of The Total Environment.

In The Last Decade

Hiroshi Uchino

112 papers receiving 5.0k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)

1998 921 citations Hiroshi Uchino et al. profile →
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines

2001 617 citations Hiroshi Uchino et al. profile →
Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) Family

2000 505 citations Hiroshi Uchino et al. Biochemical and Biophysical Research Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroshi Uchino Japan	29	1.9k	1.6k	1.0k	965	710	115	5.2k
Joseph Satriano United States	39	2.0k 1.1×	689 0.4×	362 0.4×	859 0.9×	709 1.0×	72	5.1k
Manabu Nakamura United States	35	2.7k 1.4×	1.8k 1.1×	215 0.2×	899 0.9×	1.3k 1.8×	128	6.4k
Rick G. Schnellmann United States	44	3.1k 1.6×	534 0.3×	373 0.4×	203 0.2×	548 0.8×	174	6.3k
Nanping Wang China	50	3.9k 2.0×	606 0.4×	845 0.8×	618 0.6×	1.1k 1.5×	167	7.7k
Shoji Kimura Japan	47	2.5k 1.3×	395 0.2×	1.0k 1.0×	1.6k 1.6×	1.6k 2.3×	319	8.2k
Laurent Vergnes United States	45	4.8k 2.5×	595 0.4×	574 0.6×	437 0.5×	837 1.2×	101	8.3k
Akira Sugawara Japan	56	4.7k 2.4×	371 0.2×	628 0.6×	1.8k 1.9×	1.2k 1.7×	294	10.4k
Yasushi Tamura Japan	45	4.8k 2.5×	900 0.6×	276 0.3×	636 0.7×	655 0.9×	226	8.0k
Yong Ji China	43	2.6k 1.4×	1.2k 0.8×	274 0.3×	268 0.3×	625 0.9×	165	5.6k
Jordi Muntané Spain	43	2.3k 1.2×	418 0.3×	694 0.7×	499 0.5×	1.1k 1.5×	167	5.9k

Countries citing papers authored by Hiroshi Uchino

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Uchino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Uchino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Uchino more than expected).

Fields of papers citing papers by Hiroshi Uchino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Uchino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Uchino. The network helps show where Hiroshi Uchino may publish in the future.

Co-authorship network of co-authors of Hiroshi Uchino

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Uchino. A scholar is included among the top collaborators of Hiroshi Uchino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Uchino. Hiroshi Uchino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saito, Manabu, et al.. (2025). Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes: A Retrospective Observational Multicenter Study (ORIGAMI Study). Diabetes Therapy. 17(1). 93–111.

Miyagi, Masahiko, et al.. (2025). Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study. Diabetes Metabolic Syndrome and Obesity. Volume 18. 101–111. 1 indexed citations

Hirose, Takahisa, et al.. (2025). Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY ‐ CVR study. Diabetes Obesity and Metabolism. 27(9). 5099–5107. 1 indexed citations

Uchino, Hiroshi, et al.. (2024). Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes Therapy. 15(9). 2119–2130. 2 indexed citations

Uchino, Hiroshi, et al.. (2022). Quantitative evaluation of insulin‐induced abdominal subcutaneous dystrophic tissue using shear wave elastography. Journal of Diabetes Investigation. 13(6). 1004–1010. 2 indexed citations

Uchino, Hiroshi, Masahiko Miyagi, Kazutoshi Isobe, et al.. (2021). Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan. Diabetes Metabolic Syndrome and Obesity. Volume 14. 773–781. 6 indexed citations

Uchino, Hiroshi, et al.. (2021). Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial. Diabetology International. 13(1). 124–131. 2 indexed citations

Shigiyama, Fumika, Yukio Ando, Masahiko Miyagi, et al.. (2020). Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia. Diabetes Research and Clinical Practice. 169. 108412–108412. 15 indexed citations

Miyagi, Masahiko, Hiroshi Uchino, Naoki Kumashiro, et al.. (2018). Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm. Diabetes Therapy. 9(5). 1959–1968. 1 indexed citations

10.

Uchino, Hiroshi, et al.. (2018). A case of bullous pemphigoid associated with the administration of ipragliflozin, a sodium-glucose cotransporter 2 inhibitor. 61(2). 59–63. 5 indexed citations

11.

Uchino, Hiroshi, Fumika Shigiyama, Masahiko Miyagi, et al.. (2018). Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium–glucose cotransporter 2 inhibitor: A randomized, open‐label, prospective study. Journal of Diabetes Investigation. 10(4). 1022–1031. 5 indexed citations

12.

Yoshino, Hiroshi, Naoki Kumashiro, Yukio Ando, et al.. (2017). Acute suppurative thyroiditis in infected thyroid cyst in an adult patient under hemodialysis. Clinical Case Reports. 5(5). 570–573. 4 indexed citations

13.

Uchino, Hiroshi, Masahiko Miyagi, Naoki Kumashiro, et al.. (2017). Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial. Diabetes Therapy. 8(4). 783–792. 26 indexed citations

14.

Shiota, Masaki, Akira Yokomizo, Keijiro Kiyoshima, et al.. (2010). Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box–Binding Protein 1, and E-Cadherin Regulation. Clinical Cancer Research. 16(23). 5654–5663. 76 indexed citations

15.

Furukawa, Tomohiro, Hiroshi Uchino, Hiroshi Maeda, et al.. (2009). Characteristics of troponins as myocardial damage biomarkers in cynomolgus monkeys. The Journal of Toxicological Sciences. 34(6). 589–601. 8 indexed citations

16.

Nomiyama, Takashi, Satomi Takahashi, Ken Sakai, et al.. (2007). Manganese Superoxide Dismutase Polymorphism (V16A) Associated with Impaired Cardiac Autonomic Function in Japanese Type 2 Diabetic Patients. 37(1). 27–34.

17.

Nomiyama, Takashi, Yasuhiro Igarashi, Hikari Taka, et al.. (2004). Reduction of insulin-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor substrate-1. Biochemical and Biophysical Research Communications. 320(3). 639–647. 55 indexed citations

18.

Kiyoshima, Keijiro, et al.. (2001). Seminal vesicle cyst associated with ipsilateral renal dysplasia: A report of two cases. 63(3). 147–150. 1 indexed citations

19.

Uchino, Hiroshi. (1975). Nutritional Value of S-Methylcysteine Sulfoxide. Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene). 30(3). 397–403. 2 indexed citations

20.

Uchino, Hiroshi & Yoshinori Itokawa. (1972). [Studies on nutritional value of S-methylcysteine sulfoxide. II. Splenic hypertrophy of rats on an increased S-methylcysteine sulfoxide diet and effect of S-methylcysteine sulfoxide administration on splenoectomized rats].. PubMed. 27(2). 253–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact